CATALYST Pharmacophore Models and Their Utility As Queries for Searching 3D Databases

Computer-Assisted Lead Finding and Optimization: Current Tools for Medicinal Chemistry

Volumn , Issue , 2007, Pages 223-240

  Sprague, Peter W ^a   Hoffmann, Remy ^a  

^a Molecular Simulations Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS;

3D DATABASE; BIOLOGICAL ASSAYS; ELECTRONIC DATABASE; EXPERIMENTAL APPROACHES; EXPERIMENTAL METHODS; PHARMACOPHORE MODELS; SEARCHING CAPABILITY;

QUERY PROCESSING;

EID: 84951763413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783906390406.ch14     Document Type: Chapter

References (30)

1. M.S. Tute, in 'Comprehensive Medicinal Chemistry' ed. C. Hansch, P. G. Sammes and J. B. Taylor, Pergamon Press, New York, 1990, vol. 4, p. 1.
2. G. R. Marshall, in 'Computer-Aided Molecular Design' Ed. W. G. Richards, VCH Publishers, New York, 1989, p. 91.
3. W. Sneader, in 'Comprehensive Medicinal Chemistry' ed. C. Hansch, P. G. Sammes and J. B. Taylor, Pergamon Press, New York, 1990, vol. 1, p. 7.
4. Y. C. Martin, J. Med. Chem. 1992. 35, 2145-2154, and references therein.
5. J. Greene, S. Kahn, H. Savoj, P. Sprague, S. Teig, J. Chem Inf. Comp. Sci. 1994, 34, 1297-1308.
6. Molecular Simulations Inc., 9685 Scranton Road, San Diego, CA 92121-3752.
7. A. Smellie, S. D. Kahn, S. L. Teig, J. Chem. Inf. Comp. Sci, 1995 35, 285-294; A. Smellie, S. D. Kahn, S. L. Teig, J. Chem. Inf. Comp. Sci, 1995 35, 295-304.
8. D. Barnum, J. Greene, A. Smellie, P. Sprague, J. Chem. Inf. Comput. Sci. 1996, 36, 563-571.
9. Catalyst Tutorials Release 3.1, Molecular Simulations Inc., San Diego, CA, 1996.
10. R. Fisher, 'The Principles of Experimentation, Illustrated by a Psycho-physical Experiment." Chapter II in The Design of Experiments', Eight Edition, Hafner Publishing Co., New York, 1966.
11. P. W. Sprague, in 'Perspectives in Drug Discovery and Design', Ed. K. Müller, ESCOM, Leiden, 1995, vol 3, p.l.
12. P. W. Sprague, in 'Perspectives in Drug Discovery and Design', Ed. K. Muller, ESCOM, Leiden, 1995 vol 3, p.l.
13. N. E. Kohl, S. D. Mosser, S. J. deSolms, E. A. Giuliani, D. L. Pompliano, S. L. Graham, R. L. Smith, E. M. Scolnick, A. Oliff, J. B. Gibbs, Science 1993, 260 1934-1937.
14. Protein Data Bank, Brookhaven National Laboratory, Chemistry Department, Upton, NY, 11973.
15. P. W. Sprague, in 'Perspectives in Drug Discovery and Design', Ed. K. Muller, ESCOM, Leiden, 1995 vol 3, p.l.
16. W. Bode, Biochemistry 1989, 28, 1951.
17. W. Bode, Z. Way, I. Mayr, FEBS Lett., 1988, 234, 367.
18. Insight, Version 95.0, Molecular Simulations, San Diego, CA, USA.
19. H. J. Böhm, J. Comp. Aided. Molec. Design, 1992 6, 69.
20. All Chemicals Directory (ACD), LUDI Format, Molecular Simulations, San Diego, CA, USA.
21. Derwent World Drug Index, Release 1996.02, Derwent Information Ltd. London, 1996.
22. W. J. Greenlee, Med. Res. Rev., 1990, 10, 173-236.
23. K. Müller, H. J. Ammann, D. M. Doran, P. R. Gerber, K. Gubernator, G. Schrepfer in 'Computer-Aided Molecular Design' Ed. W. Graham Richards, VCH Publishers, New York, 1989, p 119; see ref. 4; see ref 5.
24. T. Hurst, J. Chem. Inf. Comput. Sci., 1994 34, 190-196.
25. M. Lipton, W. C. Still, J. Comput. Chem. 1989, 9, 343-355; R. A. Dammkoehler, S. F. Karasek, E. F. Gerkley-Shands, G. A. Marshall, J. Comp. Aided Mol. Des. 1989, 3, 3-21; M. Saunders, H. A. Jiminez-Vasquez, J. Comput. Chem. 1993,14, 330-348.
26. Conformational Analysis in Catalyst, Technical White Paper, 1991, BioCAD Corporation (contact Molecular Simulations Inc. 9685 Scranton Road, San Diego, CA 92121-3752).
27. A. Smellie, S. L. Teig, P. Towbin, J. Comp. Chem. 1995, 76, 171-187.
28. 2 Diversity, Molecular Simulations Inc. 9685 Scranton Road, San Diego, CA 92121-3752.
29. DB searches were done to find all compounds with the word 'angiotensin' in the mode of action field, and all compounds with 'pril' in the name field. The hits from these searches were evaluated visually and only those compounds recognizable as non-peptide ACE inhibitors were retained.
30. P. W. Sprague Building A Hypothesis for Angiotensin II Antagonism, Application Note, BioCAD Corp., Sunnyvale, CA, 1994 (contact Molecular Simulations Inc., San Diego, CA).